Company Overview of Constellation Pharmaceuticals, Inc.
Key Executives for Constellation Pharmaceuticals, Inc.
|Jigar Raythatha||11 Relationships||Chief Executive Officer and President||--|
|David Allis Ph.D.||20 Relationships||Co-Founder||--|
|Mark A. Goldsmith M.D., Ph.D.||31 Relationships||Executive Chairman||54|
|Danny Reinberg Ph.D.||No Relationships||Co-Founder||--|
|Yang Shi Ph.D.||No Relationships||Co-Founder||--|
|View More Key Executives|
Constellation Pharmaceuticals, Inc. Board Members*
|Name||Board Relationships||Primary Company||Age|
|Mark A. Goldsmith M.D., Ph.D.||31 Relationships||REVOLUTION Medicines, Inc.||54|
|Anthony B. Evnin Ph.D.||128 Relationships||Venrock||75|
|David V. Goeddel Ph.D.||66 Relationships||The Column Group LLC||64|
|Robert I. Tepper M.D.||42 Relationships||Third Rock Ventures, LLC||60|
|David Morse Livingston M.D.||37 Relationships||Dana-Farber Cancer Institute, Inc.||74|
Constellation Pharmaceuticals, Inc. Executive Committees*
|Committee Name||Chairperson||Board Relationships||Members|
|There is no committee data available.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
CEO COMPENSATION IN THIS INDUSTRY
|Total Short Term Compensation|
|Total Value of Options|
INDUSTRY EXECUTIVE CHANGES
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.